Document is current

Any future updates will be listed below

Association between screening duration and treatment outcomes in the clinical trials of ranibizumab and aflibercept for neovascular age-related macular degeneration

Crossref DOI link: https://doi.org/10.1038/s41598-026-41200-3

Published Online: 2026-04-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark